User profiles for María Peña-Chilet

Maria Peña-Chilet

Clinical Bioinformatics Area - CIBERER
Verified email at alumni.uv.es
Cited by 1322

Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy

…, P Mondelo-Macía, M Peña-Chilet… - Cancer Immunology …, 2021 - Springer
Immunotherapy has been one of the great advances in the recent years for the treatment of
advanced tumors, with nonsmall-cell lung cancer (NSCLC) being one of the cancers that has …

[HTML][HTML] Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients

C Loucera, M Peña-Chilet, M Esteban-Medina… - Scientific reports, 2021 - nature.com
COVID-19 is a major worldwide health problem because of acute respiratory distress
syndrome, and mortality. Several lines of evidence have suggested a relationship between the …

[HTML][HTML] Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection

…, K Rian, MM Falco, J Dopazo, M Peña-Chilet - Signal transduction and …, 2020 - nature.com
Drug repurposing is a convenient alternative when the need for new drugs in an unexpected
medical scenario is urgent, as is the case of emerging pathogens. In recent years, …

High stability of microRNAs in tissue samples of compromised quality

L Peiró-Chova, M Peña-Chilet, JA López-Guerrero… - Virchows archiv, 2013 - Springer
Degradation of tissue samples limits performing RNA-based molecular studies, but little is
known about the potential usefulness of samples of compromised quality for studies focused …

CSVS, a crowdsourcing database of the Spanish population genetic variability

M Peña-Chilet, G Roldán, J Perez-Florido… - Nucleic acids …, 2021 - academic.oup.com
The knowledge of the genetic variability of the local population is of utmost importance in
personalized medicine and has been revealed as a critical factor for the discovery of new …

[HTML][HTML] Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial

…, E de Alava, P Collini, M Peña-Chilet… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Sarcomas exhibit low expression of factors related to immune response, which
could explain the modest activity of PD-1 inhibitors. A potential strategy to convert a cold into …

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

…, A Gutierrez, DS Moura, M Peña-Chilet… - The Lancet …, 2019 - thelancet.com
Background A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological
variants: typical, malignant, and dedifferentiated. Preclinical experiments and …

COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms

…, M Esteban‐Medina, M PeñaChilet… - Molecular systems …, 2021 - embopress.org
We need to effectively combine the knowledge from surging literature with complex datasets
to propose mechanistic models of SARS‐CoV‐2 infection, improving data interpretation and …

[HTML][HTML] Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women

SS Oltra, M Peña-Chilet, V Vidal-Tomas, K Flower… - Scientific reports, 2018 - nature.com
MiRNAs are part of the epigenetic machinery, and are also epigenetically modified by DNA
methylation. MiRNAs regulate expression of different genes, so any alteration in their …

[HTML][HTML] A comprehensive database for integrated analysis of omics data in autoimmune diseases

…, F Al-Shahrour, V González-Rumayor, M Peña-Chilet… - BMC …, 2021 - Springer
Background Autoimmune diseases are heterogeneous pathologies with difficult diagnosis
and few therapeutic options. In the last decade, several omics studies have provided …